Korean J Helicobacter  Up Gastrointest Res Search

CLOSE


Korean J Helicobacter  Up Gastrointest Res > Volume 25(2); 2025 > Article
Lee: Bridging the Gap in Management of Gastric Subepithelial Lesions: Time for Standardized Care
Gastric subepithelial lesions (SELs) are often incidentally detected during upper endoscopy and typically appear as mucosa-covered elevations of the gastric wall. While most are benign and asymptomatic, some may represent potentially malignant tumors such as gastrointestinal stromal tumors (GISTs). Because SELs are located beneath the mucosal layer, conventional endoscopic biopsy often fails to provide an accurate histological diagnosis, making their management particularly challenging [1-3].
International guidelines generally recommend regular follow-up rather than immediate biopsy or resection for asymptomatic SELs smaller than 2 cm. However, when GIST is confirmed histologically, complete removal is advised regardless of size [4,5]. In Korea, a standardized guideline for managing such lesions is lacking, resulting in significant variability among clinicians in diagnostic and therapeutic approaches.
In this context, Kim et al. [6] conducted a nationwide multicenter survey of Korean gastroenterologists from various levels of healthcare institutions to elucidate current practice patterns regarding the diagnosis and management of asymptomatic gastric SELs. Their findings revealed substantial variation in the clinical approach to asymptomatic gastric SELs, largely influenced by lesion size and institutional capacity. For lesions smaller than 1 cm, most physicians (70.4%) preferred regular endoscopic follow-up without performing biopsies, reflecting a conservative stance toward very small SELs. However, once lesions reached 2–3 cm, clinical behavior shifted—physicians at primary and secondary institutions often referred patients to higher-level centers, while those in tertiary hospitals were more likely to perform endoscopic ultrasound-guided biopsies (40.4%). Endoscopic resection was another key area of variation. It was predominantly performed in tertiary hospitals, with only 4.1% of lower-level institutions reporting its use, compared to 32.8% in tertiary care. Interestingly, 75.7% of all respondents felt that endoscopic resection is appropriate for SELs under 3 cm, suggesting a shared threshold for intervention.
This study is the first to provide a comprehensive national overview of current clinical practices for managing asymptomatic gastric SELs in Korea. By categorizing responses based on healthcare level, the study sheds light on how resource availability and institutional experience shape diagnostic and treatment decisions. Importantly, a majority of gastroenterologists agreed that 2–3 cm represents a key threshold at which more active intervention—including biopsy or resection—should be considered. At the same time, the study raises important questions that still need answers—such as whether all SELs in this size range should be removed, and how smaller lesions should be followed over time. To answer these questions and improve patient care, further studies are needed. The findings of this nationwide survey highlight the urgent need for standardized guidelines in the management of asymptomatic gastric SELs in Korea.
Importantly, the upcoming guideline on the diagnosis and endoscopic management of gastric subepithelial tumors, soon to be released by the Korean College of Helicobacter and Upper Gastrointestinal Research, is expected to address many of these unanswered questions. It is anticipated that this guideline will serve as a practical and reliable reference for gastroenterologists across Korea, supporting more consistent, evidence-based care.

Notes

Availability of Data and Material

Data sharing not applicable to this article as no datasets were generated or analyzed during the study.

Conflicts of Interest

The author has no financial conflicts of interest.

Funding Statement

None

Acknowledgements

None

REFERENCES

1. Kim GH. Systematic endoscopic approach for diagnosing gastric subepithelial tumors. Gut Liver 2022;16:19–27.
crossref pmid pmc
2. Cho JW.; Korean ESD Study Group. Current guidelines in the management of upper gastrointestinal subepithelial tumors. Clin Endosc 2016;49:235–240.
crossref pmid pmc pdf
3. Lee MW, Lee BE. Approach to small gastric subepithelial lesions. Korean J Helicobacter Up Gastrointest Res 2023;23:28–33.
crossref pmid pmc pdf
4. Deprez PH, Moons LMG, O’Toole D, et al. Endoscopic management of subepithelial lesions including neuroendocrine neoplasms: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 2022;54:412–429.
crossref pmid
5. Faulx AL, Kothari S, Acosta RD, et al. The role of endoscopy in subepithelial lesions of the GI tract. Gastrointest Endosc 2017;85:1117–1132.
crossref pmid
6. Kim SH, Park JY, Lee A, et al. Current practices in histological diagnosis and management of asymptomatic gastric subepithelial lesions: a multicenter survey in Korea. Korean J Helicobacter Up Gastrointest Res 2025;25:159–166.
crossref pdf


Editorial Office
Lotte Gold Rose II Room 917, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-717-5543    Fax: +82-2-565-9947    E-mail: kjhugr@kams.or.kr                

Copyright © 2025 by Korean College of Helicobacter and Upper Gastrointestinal Research.

Developed in M2PI

Close layer
prev next